Analysis of the TLR/NF-kappaB pathway in antigen-presenting cells in malignancies promoted by inflammation
- PMID: 19347275
- DOI: 10.1007/978-1-60327-530-9_7
Analysis of the TLR/NF-kappaB pathway in antigen-presenting cells in malignancies promoted by inflammation
Abstract
Activation of the transcription factor, nuclear factor of kappaB (NF-kappaB), has recently emerged as the critical link between inflammation and cancer. NF-kappaB is activated by many signals including DNA damage and microbial pathogen recognition. Although microbial infections account for an estimated 15% of all cancer related deaths, NF-kappaB is constitutively activated in various types of cancer as a direct result of chromosomal translocations, deletions and mutations affecting both NF-kappaB and its regulators. NF-kappaB exerts the transcriptional activation and repression of inflammatory and immune response genes as well as genes mediating cell survival and proliferation, and thus stands to impact various cellular processes. The decision is made through the integration of the pathway of NF-kappaB activation with a complex array of cell signaling networks that are at present poorly understood. Here, two methods are presented, protein co-immunoprecipitation and subcellular co-localization by immunofluorescence microscopy, to help investigations into the links between NF-kappaB-induced inflammation and cancer. Understanding the details of these pathways will aid in the development of new diagnostic and therapeutic applications.
Similar articles
-
The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.Methods Mol Biol. 2009;512:169-207. doi: 10.1007/978-1-60327-530-9_10. Methods Mol Biol. 2009. PMID: 19347278
-
Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway.Am J Reprod Immunol. 2007 Feb;57(2):93-107. doi: 10.1111/j.1600-0897.2006.00441.x. Am J Reprod Immunol. 2007. PMID: 17217363 Review.
-
NF-kappaB signaling pathway and its therapeutic implications in human diseases.Int Rev Immunol. 2008;27(5):293-319. doi: 10.1080/08830180802276179. Int Rev Immunol. 2008. PMID: 18853341 Review.
-
Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling.Cell Mol Immunol. 2007 Feb;4(1):31-41. Cell Mol Immunol. 2007. PMID: 17349209 Review.
-
Nuclear factor-kappaB activation: from bench to bedside.Exp Biol Med (Maywood). 2008 Jan;233(1):21-31. doi: 10.3181/0707-MR-196. Exp Biol Med (Maywood). 2008. PMID: 18156302 Review.
Cited by
-
Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study.BMC Cancer. 2013 May 1;13:219. doi: 10.1186/1471-2407-13-219. BMC Cancer. 2013. PMID: 23634849 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources